Altogether, these data support that ADAMTS-12 fibulin-2/ interaction hampers both invasion and migration of breast cancer cells in vitro, but also that ADAMTS-12 could exert pro-tumor effects in the absence of fibulin-2. This evidence concerns the gene FBLN2 and breast carcinoma.